Evidence map›Paper›PMID 25771346›Full record

ArticleDifferentiation; research in biological diversity

The cellular and molecular progression of mitochondrial dysfunction induced by 2,4-dinitrophenol in developing zebrafish embryos.

Jennifer E Bestman, Krista D Stackley, Jennifer J Rahn, Tucker J Williamson, Sherine S L Chan

Abstract read
In one paragraph

Article in Differentiation; research in biological diversity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Niclosamide Induces Epiboly Delay During Early Zebrafish Embryogenesis.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Article
  14. Mitochondrial Toxicity.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Triclosan is a mitochondrial uncoupler in live zebrafish.Journal of applied toxicology : JAT · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jennifer E BestmanMedical University of South Carolina, Drug Discovery & Biomedical Sciences, 280 Calhoun Street, MSC 140, QE 219A, Charleston, SC 29425, USA.
Krista D StackleyMedical University of South Carolina, Drug Discovery & Biomedical Sciences, 280 Calhoun Street, MSC 140, QE 219A, Charleston, SC 29425, USA.
Jennifer J RahnMedical University of South Carolina, Drug Discovery & Biomedical Sciences, 280 Calhoun Street, MSC 140, QE 219A, Charleston, SC 29425, USA.
Tucker J WilliamsonMedical University of South Carolina, Drug Discovery & Biomedical Sciences, 280 Calhoun Street, MSC 140, QE 219A, Charleston, SC 29425, USA.
Sherine S L ChanMedical University of South Carolina, Drug Discovery & Biomedical Sciences, 280 Calhoun Street, MSC 140, QE 219A, Charleston, SC 29425, USA. Electronic address: chans@musc.edu.
Medical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20RR024485 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2011 to 2011
$2.2M
Adverse Actions of Stimulants on Embryonic Development and EnergeticsR21DA037706 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHAN, SHERINE S · 2014 to 2015
$409k
NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1TR000062NCI NIH HHS P30 CA138313NCRR NIH HHS 5P20RR024485-02NCRR NIH HHS P20 RR024485NHLBI NIH HHS T32 HL007260NIDA NIH HHS R21 DA037706NIGMS NIH HHS 8P20 GM103542-02NIGMS NIH HHS P20 GM103542
6 · The paper itself

Abstract

The etiology of mitochondrial disease is poorly understood. Furthermore, treatment options are limited, and diagnostic methods often lack the sensitivity to detect disease in its early stages. Disrupted oxidative phosphorylation (OXPHOS) that inhibits ATP production is a common phenotype of mitochondrial disorders that can be induced in zebrafish by exposure to 2,4-dinitrophenol (DNP), a FDA-banned weight-loss agent and EPA-regulated environmental toxicant, traditionally used in research labs as an uncoupler of OXPHOS. Despite the DNP-induced OXPHOS inhibition we observed using in vivo respirometry, the development of the DNP-treated and control zebrafish were largely similar during the first half of embryogenesis. During this period, DNP-treated embryos induced gene expression of mitochondrial and nuclear genes that stimulated the production of new mitochondria and increased glycolysis to yield normal levels of ATP. DNP-treated embryos were incapable of sustaining this mitochondrial biogenic response past mid-embryogenesis, as shown by significantly lowered ATP production and ATP levels, decreased gene expression, and the onset of developmental defects. Examining neural tissues commonly affected by mitochondrial disease, we found that DNP exposure also inhibited motor neuron axon arbor outgrowth and the proper formation of the retina. We observed and quantified the molecular and physiological progression of mitochondrial dysfunction during development with this new model of OXPHOS dysfunction, which has great potential for use in diagnostics and therapies for mitochondrial disease.

Indexed as

2,4-DinitrophenolAdenosine TriphosphateAnimalsEmbryonic DevelopmentEnergy MetabolismGene Expression Regulation, DevelopmentalHumansMitochondriaMitochondrial DiseasesMotor NeuronsOxidative PhosphorylationRetinaZebrafish2,4-DinitrophenolAdenosine TriphosphateEmbryoEnergy metabolismIn vivo respirometryMotor neuronRetinaZebrafish

Identifiers

PMID25771346
PMCPMC4466198
OpenAlexW2060912187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.